MJP Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-775
Closed -$214K – 258
2025
Q2
$214K Buy
+775
New +$211K 0.03% 214
2024
Q3
– Sell
-1,100
Closed -$216K – 220
2024
Q2
$216K Sell
1,100
-30
-3% -$6.2K 0.05% 213
2024
Q1
$243K Buy
+1,130
New +$237K 0.05% 202
2023
Q4
– Sell
-1,003
Closed -$201K – 185
2023
Q3
$201K Buy
+1,003
New +$199K 0.06% 163
2022
Q3
– Sell
-983
Closed -$201K – 132
2022
Q2
$201K Buy
983
+53
+6% +$11.2K 0.06% 132
2022
Q1
$221K Buy
+930
New +$218K 0.06% 144

Other funds holding CME

MJP Associates's CME Position: Q3 2025 in Review

MJP Associates sold out of CME Group (CME) in Q3 2025, closing a stake of 775 shares — an estimated $214K sold.

MJP Associates first reported a position in CME in Q1 2022 and held it in 6 quarters. The position peaked at $243K in Q1 2024. 1,653 funds tracked by Wall St. Rank hold CME as of Q3 2025.

  • MJP Associates reported no remaining CME Group position as of Q3 2025 after selling out during the quarter.
  • MJP Associates sold 775 CME Group shares in Q3 2025, an estimated $214K.
  • MJP Associates first reported a position in CME Group in Q1 2022 and held it in 6 quarters.
  • MJP Associates's CME Group position peaked at $243K in Q1 2024.
  • 1,653 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on MJP Associates's 13F filing for Q3 2025, filed 7 Nov 2025.